BIOVALLEY

China
Kunming, Yunnan, China

Company profile

BIOVALLEY company profile

Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.

Business identity

Phone number
0871-65016111
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Founded
1999-06-13

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$22.3M
Last funding
Post IPO Equity / $22.3M / 2016-10-12
Last equity funding
Post IPO Equity / $22.3M
Investors
1
Articles
1
Exited on
2015-08-11

Founders and investors

Investors

ShenZhen GTJA Investment Group